Tizona Therapeutics

Gilead will not buy Tizona after paying $300M for the right to do so
Fierce Biotech
Wed, 02/7/24 - 11:17 am
Gilead Sciences
Tizona Therapeutics
M&A
oncology
Gilead rescues biopharma’s takeout scene
EP Vantage
Wed, 10/7/20 - 11:02 am
M&A
Gilead Sciences
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Nestle
Aimmune
Tizona Therapeutics
Gilead Sciences to pay $300 million for nearly half of Tizona, has option to buy the rest for $1.25 billion
Marketwatch
Tue, 07/21/20 - 10:28 am
Gilead Sciencs
Tizona Therapeutics
M&A
cancer
AbbVie puts up $105M for Tizona's preclinical I/O drug
BioPharma Dive
Sat, 01/5/19 - 12:04 am
AbbVie
Tizona Therapeutics
TTX-030
immuno-oncology